JP2012500261A5 - - Google Patents

Download PDF

Info

Publication number
JP2012500261A5
JP2012500261A5 JP2011523814A JP2011523814A JP2012500261A5 JP 2012500261 A5 JP2012500261 A5 JP 2012500261A5 JP 2011523814 A JP2011523814 A JP 2011523814A JP 2011523814 A JP2011523814 A JP 2011523814A JP 2012500261 A5 JP2012500261 A5 JP 2012500261A5
Authority
JP
Japan
Prior art keywords
agent
ribose
effective amount
life
decrease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011523814A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012500261A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/004738 external-priority patent/WO2010021713A1/en
Publication of JP2012500261A publication Critical patent/JP2012500261A/ja
Publication of JP2012500261A5 publication Critical patent/JP2012500261A5/ja
Withdrawn legal-status Critical Current

Links

JP2011523814A 2008-08-20 2009-08-20 疲労した対象のためのd−リボースの使用 Withdrawn JP2012500261A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US18949808P 2008-08-20 2008-08-20
US61/189,498 2008-08-20
US20812209P 2009-02-20 2009-02-20
US61/208,122 2009-02-20
PCT/US2009/004738 WO2010021713A1 (en) 2008-08-20 2009-08-20 Use of d-ribose for fatigued subjects

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015095225A Division JP2016014009A (ja) 2008-08-20 2015-05-07 疲労した対象のためのd−リボースの使用

Publications (2)

Publication Number Publication Date
JP2012500261A JP2012500261A (ja) 2012-01-05
JP2012500261A5 true JP2012500261A5 (enExample) 2012-10-04

Family

ID=41172394

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011523814A Withdrawn JP2012500261A (ja) 2008-08-20 2009-08-20 疲労した対象のためのd−リボースの使用
JP2015095225A Pending JP2016014009A (ja) 2008-08-20 2015-05-07 疲労した対象のためのd−リボースの使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015095225A Pending JP2016014009A (ja) 2008-08-20 2015-05-07 疲労した対象のためのd−リボースの使用

Country Status (8)

Country Link
US (2) US20100189785A1 (enExample)
EP (1) EP2323668A1 (enExample)
JP (2) JP2012500261A (enExample)
CN (2) CN105232564A (enExample)
AU (1) AU2009283215B2 (enExample)
BR (1) BRPI0917360A2 (enExample)
CA (1) CA2734769A1 (enExample)
WO (1) WO2010021713A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102387805A (zh) * 2008-04-02 2012-03-21 生物能公司 核糖在对于急性心肌梗塞的第一反应中的用途
CN102488669A (zh) * 2011-12-30 2012-06-13 上海希迪制药有限公司 一种改善d-核糖引湿性的方法
JP2017537079A (ja) * 2014-11-03 2017-12-14 バイオエナジー ライフ サイエンス,インコーポレイティド 身体的ストレスへの適応を強化するためのd−リボースの使用
WO2017120731A1 (en) * 2016-01-11 2017-07-20 Shanghai Yao Yuan Biotechnology Co., Ltd. Methods and compositions for reducing body weight
JP6542687B2 (ja) 2016-01-28 2019-07-10 日本特殊陶業株式会社 ガスセンサユニット
US10434113B2 (en) 2016-12-16 2019-10-08 The Charlotte Mecklenburg Hospital Authority Compositions and methods for treating muscular dystrophy and other disorders
WO2019200132A1 (en) * 2018-04-12 2019-10-17 Metabolic Recovery Systems, LLC Compositions and methods for supplementing the diet
WO2020041750A1 (en) * 2018-08-24 2020-02-27 The Charlotte Mecklenburg Hospital Authority D/B/A Atrium Health Methods and compositions for treating disorders associated with muscle weakness
KR102435548B1 (ko) * 2022-05-31 2022-08-26 (주)에이피테크놀로지 액상스틱형 에너지 스포츠 음료

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4228215A1 (de) * 1992-08-25 1994-03-03 Pliml Wolfgang Verwendung von Ribose zur Herstellung eines Arzneimittels zur Behandlung von Leistungsschwächen des Körpers, insbesondere von Organinsuffizienzen
US6159942A (en) * 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
EP1745789A1 (en) * 1998-06-19 2007-01-24 Bioenergy Inc. Compositions comprising ribose for increasing energy in vivo
US6159943A (en) * 1999-09-24 2000-12-12 Bioenergy, Inc. Use of ribose to prevent cramping and soreness in muscles
GB2353217B (en) * 1999-10-27 2001-07-18 Bioenergy Inc Use of ribose to treat fibromyalgia
US6420342B1 (en) * 2000-05-08 2002-07-16 N.V. Nutricia Nutritional preparation comprising ribose and medical use thereof
IT1317043B1 (it) * 2000-06-14 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare potenziante il metabolismo energeticomuscolare, comprendente una alcanoil l-carnitina e ribosio.
US6855727B2 (en) * 2000-12-04 2005-02-15 Yaizu Suisankagaku Industry Co., Ltd. Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect
EP1734974A1 (en) * 2004-03-18 2006-12-27 Tanabe Seiyaku Co., Ltd. D-ribose for improving depression-like symptoms
US20100099630A1 (en) * 2004-04-29 2010-04-22 Maccarter Dean J Method for improving ventilatory efficiency
WO2005107768A2 (en) * 2004-04-29 2005-11-17 Bioenergy, Inc. Method for improving ventilatory efficiency
US7645742B2 (en) * 2005-06-22 2010-01-12 Advocare International, L.P. Composition for enhancing cellular energy
WO2022123637A1 (ja) 2020-12-07 2022-06-16 株式会社日立製作所 文書処理システムおよび文書処理方法

Similar Documents

Publication Publication Date Title
WO2008149802A1 (ja) アンドログラホリドを有効成分とする抗疲労剤及び経口組成物
JP2009541479A5 (enExample)
JP2014518860A5 (enExample)
NZ611628A (en) Use of laquinimod for reducing fatigue, improving functional status, and improving quality of life in multiple sclerosis patients
JP2009084294A5 (enExample)
FI3457135T3 (fi) Fabryn taudin hoitovaihtoehtoja
NO20085374L (no) Anvendelse av fytat som middel for a inhibere opplosning av krystaller av kalsiumsalter for forhindring av osteoporose
WO2011019735A3 (en) Nutritional supplements
JP2011510922A5 (enExample)
MY139913A (en) Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance
JP2016050198A (ja) 睡眠障害改善剤
JP2005524629A5 (enExample)
JP2008266291A5 (enExample)
JP6947495B2 (ja) Gabaを有効成分とする活気および/または活力向上剤
JP2013032308A5 (enExample)
Lee et al. Nutrition support in the intensive care unit of 6 Korean tertiary teaching hospitals: a national multicenter observational study
Huijer Chronic pain: a review
JP2011225504A (ja) Tarc産生抑制剤
JP2017527591A (ja) 認知機能向上のための植物抽出物
EP1733631A4 (en) FOOD COMPOSITION WITH ANTISTRESS EFFECT
Persson et al. Age your garlic for longevity!
WO2010142400A3 (de) Zusammensetzungen auf basis von chitosan-oligosacchariden
WO2009057033A3 (en) Computing a user's condition
BR212013002823U2 (pt) material de baixa densidade para ser usado como núcleo
CN101595933A (zh) 一种具有提神功能的口香糖